(Q53302797)

English

Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma.

scientific article published in October 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

author name string

Hirotaka Fukasawa

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Tatsuo Yamamoto

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Yoshihide Fujigaki

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Taro Misaki

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Naro Ohashi

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Tatsuya Takayama

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Sayuri Suzuki

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Soichi Mugiya

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Toshiaki Oda

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Chiharu Uchida

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Kyoko Kitagawa

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Takayuki Hattori

12

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Hidetoshi Hayashi

13

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Seiichiro Ozono

14

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Masatoshi Kitagawa

15

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Akira Hishida

16

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

language of work or name

0 references

publication date

1 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

127

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

1517-1525

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

Transforming growth factor-beta: recent progress and new challenges

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Regulation of Smad activity

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Genomic profiling identifies alterations in TGFbeta signaling through loss of TGFbeta receptor expression in human renal cell carcinogenesis and progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Transforming growth factor-beta type II receptor confers tumor suppressor activity in murine renal carcinoma (Renca) cells

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

The ubiquitin system

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Ubiquitin-mediated proteolysis: biological regulation via destruction

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

TGF beta signals through a heteromeric protein kinase receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Down-regulation of Smad7 expression by ubiquitin-dependent degradation contributes to renal fibrosis in obstructive nephropathy in mice

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Ubiquitin-Dependent Degradation of Smad2 Is Increased in the Glomeruli of Rats with Anti-Thymocyte Serum Nephritis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Grading systems in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Phase II trial of bortezomib for patients with advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Role of transforming growth factor-beta signaling in cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

TGF-beta signaling in tumor suppression and cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Smads as transcriptional co-modulators

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Differential ubiquitination defines the functional status of the tumor suppressor Smad4.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

The von Hippel-Lindau tumor suppressor gene and kidney cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25164

21 January 2018

Identifiers

10.1002/IJC.25164

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/20073064

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53302797&oldid=1237375735"